Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).

Bibliographic Details
Title:	Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).
Authors:	Aspinall, Richard J.¹ aspinall@doctors.org.uk, Hudson, Mark², Ryder, Stephen D.³, Richardson, Paul⁴, Farrington, Elizabeth⁵, Wright, Mark⁶, Przemioslo, Robert T.⁷, Perez, Francisco⁸, Kent, Melanie⁸, Henrar, Roland⁹, Hickey, Joe¹⁰, Shawcross, Debbie L.¹¹
Source:	Frontline Gastroenterology. May2023, Vol. 14 Issue 3, following p228-235. 14p.
Database:	Academic Search Complete

More Details
ISSN:	20414137
DOI:	10.1136/flgastro-2022-102221
Published in:	Frontline Gastroenterology
Language:	English